Awards and Recognitions
Dr. Kamaljit Kaur co-organized/co-chaired a symposium titled “From Link to Lead: Impact of Linkers on Drug Discovery,” at the 2026 ACS Fall Meeting and Exposition in Chicago, IL, USA, on Aug 23-27, 2026.
Publications
Dr. Keykavous Parang, Dr. Hamid Montazeri Aliabadi, Abdulelah Alhazza, Sorour Khayyatnejad Shoushtari, and others published “Charge Modulation of Peptide/Nucleic Acid Complexes: An Anionic Additive Enhances Gene Silencing and CRISPR/Cas9 Editing by Promoting Intracellular Nucleic Acid Release,” in Frontiers in Nanotechnology.
Dr. Innokentiy Maslennikov, Dr. Mamta Iyer, Dr. Simin Rahighi, and others published “Design of a chimeric probe specific to K48-K63-linked heterotypic ubiquitin chains,” in Scientific Reports.
Dr. Keykavous Parang and Emmanuel Fashesin Souza published “Nicotine pouches: Harm reduction or initiation pathway? A pharmacy-focused review,” in the Journal of the American Pharmacists Association.
Presentations
Oral (e.g., Platform Presentations, Symposiums, Plenaries, Keynotes)
- Dr. Kamaljit Kaur presented “Identification of Keratin 1 as a Novel Cell Surface Receptor for Targeted Therapeutic Delivery in Triple-Negative Breast Cancer,” at the 2026 ACS Fall Meeting in Chicago, IL, USA, on August 23-27, 2026.
- Dr. Ajay Sharma presented an invited talk, “Targeting Fibroblast-Derived Chemokines in Ocular Graft versus Host Disease-Associated Conjunctival and Lacrimal Gland Fibrosis and Scarring,” at the XXVII Biennial Meeting of the International Society for Eye Research in Valencia, Spain on August 23-27, 2026.
Posters
- Dr. Kamaljit Kaur, Basir Syed, and Keon Jafari presented “Design and Synthesis of an EGFR-Targeted Peptide-Drug Conjugate for Targeted Drug Delivery in Triple-Negative Breast Cancer,” at the 2026 ACS Fall Meeting in Chicago, IL, USA on August 23-27, 2026.
